US Patent 11833210 ASH1L inhibitors and methods of treatment therewith
Article
Patent abstract
Provided herein are small molecules that bind to ASH1L and inhibit ASH1L activity, and methods of use thereof for the treatment of disease, including acute leukemia, solid cancers and other diseases dependent on activity of ASH1L.